                         SEQUENCE LISTING

<110>  The Regents of the University of Colorado, a body corporate
       Herson, Paco S.
 
<120>  PEPTIDE-BASED METHODS FOR TREATING NEUROLOGICAL INJURY

<130>  2848-202-PCT

<140>  Not yet assigned
<141>  2017-02-23

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

Gly Ser Arg Glu Pro Gly Glu Met Leu Pro Arg Lys Leu Lys Arg Val 
1               5                   10                  15      


Leu Arg Gln Glu Phe Trp Val 
            20              


<210>  2
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  2

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  3
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  3

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Arg Glu Pro 
1               5                   10                  15      


Gly Glu Met Leu Pro Arg Lys Leu Lys Arg Val Leu Arg Gln Glu Phe 
            20                  25                  30          


Trp Val 
        


<210>  4
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<400>  4

Xaa Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  5
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  5

Phe Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  6

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10  


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  7

Gly Ser Ser Ser Ser 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  8

Thr Gly Glu Lys Pro 
1               5   


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  9

Gly Gly Arg Arg Gly Gly Gly Ser 
1               5               


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  10

Leu Arg Gln Arg Asp Gly Glu Arg Pro 
1               5                   


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  11

Gly Ser Arg Val Gln Ile Arg Cys Arg Phe Arg Asn Ser Thr Arg 
1               5                   10                  15  


